Latest KFF Health News Stories
Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?
The July 9 directive addresses the importation of prescription drugs and broader efforts to reduce the high cost of medicines.
Hospital ‘Trauma Centers’ Charge Enormous Fees to Treat Minor Injuries and Send People Home
Only severely injured patients are supposed to be billed for “trauma team alert” fees that can exceed $50,000.
Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.
Adolescentes voluntarios se abren paso como futuros profesionales en hogares de adultos mayores
Desde que se puso en marcha en 2006, el programa de desarrollo para la carrera en geriatría ha ayudado a más de 700 estudiantes de secundaria de 10 escuelas de bajos recursos, en la ciudad de Nueva York, a adquirir experiencia práctica en cuidados geriátricos.
Teen Volunteers Get a Foot in the Door for Nursing Home Careers
A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home
Your dutiful columnist tried to make use of a federal “transparency” rule to compare the prices of common medical procedures in two California health care systems. It was a futile exercise.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
KHN’s ‘What the Health?’: Un-Trumping the ACA
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
A Hospital Charged $722.50 to Push Medicine Through an IV. Twice.
A college student never got an answer for what caused her intense pain, but she did get a bill that totaled $18,736 for an ER visit. She and her mom, a nurse practitioner, fought to understand all the charges.
Covid’s Lingering Effects Can Put the Brakes on Elective Surgeries
Even after recovering from covid, many patients experience respiratory or other problems and, since this effect of the virus is so unpredictable, medical experts aren’t sure when it is safe to undergo elective surgery. But medical experts are setting up guidelines.
Doctors’ Lobby Scores ‘Major Victory’ on Bill to Hold Physicians Accountable
Patients and some lawmakers have long blasted the Medical Board of California for failing to discipline negligent or abusive physicians. But the politically powerful California Medical Association, which represents doctors, has mobilized against the latest attempt to give the board more money and power to investigate complaints.
No Vacancy: How a Shortage of Mental Health Beds Keeps Kids Trapped Inside ERs
What’s known as emergency room boarding of psychiatric patients has risen between 200% and 400% monthly in Massachusetts during the pandemic — and the problem is widespread. The CDC says emergency room visits after suicide attempts among teen girls were up 51% earlier this year as compared with 2019.
Hemmed In at Home, Nonprofit Hospitals Look for Profits Abroad
About three dozen elite health systems are involved in for-profit hospital projects overseas. Though the systems are exempt from U.S. taxes for providing “community benefit,” there’s limited evidence that such business ventures benefit American patients.
The Hard Realities of a ‘No Jab, No Job’ Mandate for Health Care Workers
Despite a hearts-and-minds campaign and millions spent in incentives, managers struggle to get staffs vaccinated against covid. Some workers have threatened to quit over the pressure to get a shot, which employers can’t afford.
Device Makers Have Funneled Billions to Orthopedic Surgeons Who Use Their Products
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
In Alleged Health Care ‘Money Grab,’ Nation’s Largest Hospital Chain Cashes In on Trauma Centers
HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.
Doctor on Call? Lawmakers Debate How Much to Pay for Phone Appointments
Phone visits became an option for many Medicare and Medicaid patients during the pandemic. Now policymakers are deciding whether they’re worth the money.
KHN’s ‘What the Health?’: Our 200th Episode!
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say
Safety-net clinics especially are bracing for how the drugmaker’s policy shift could reduce their budgets and hamstring their ability to provide care to an at-risk population.
